Cite

    Alirezaei, T. et al. (2022). Significant decrease in plasmad‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism. Clinical cardiology. 45 (7), pp. 717-722. [Online].